Fig. 4From: Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapyKaplan–Meier survival curves for the risk factors (a) and different risk stratifications (b)Back to article page